Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3370
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT06896201 Comfortage-P4 — Comfortage - AD Prevention Strategies |
Blood Exams, Fluid Biomarkers, Ge… | Alzheimer | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | Fondazione Policlinico Universita… | Italy · Fondazione Policlinico Universitario Agostino… | 2025-10-07 → 2027-03 | Ouvrir |
| NCT06703541 ADRC Clinical Cohort (Alzheimer's Disease) |
ADRC Clinical Cohort (Alzheimer's… | Alzheimer | À vérifier | RECRUITING | En attente / non publié | Duke University | United States · Duke University, Durham, United States | 2020-07-21 → 2029-07-31 | Ouvrir |
| NCT07803055 GLEVAD — Longitudinal Profiling of Plasma-Derived Glial Extracellular V… |
blood sampling | Alzheimer | Non applicable | RECRUITING | En attente / non publié | Fondazione Policlinico Universita… | Italy · Fondazione Policlinico Agostino Gemelli IRCCS… | 2026-05-18 → 2028-05-18 | Ouvrir |
| NCT04810104 PD-MIND — Parkinson's Disease With Mild Cognitive Impairment Treated Wi… |
AZD0328 | Parkinson | Phase 2 | WITHDRAWN | En attente / non publié | King's College London | Non communiqué | 2022-10 → 2024-04 | Ouvrir |
| NCT05413291 Natural History Protocol for Movement Disorders |
Natural History Protocol for Move… | Parkinson | À vérifier | RECRUITING | En attente / non publié | National Institute of Neurologica… | United States · National Institutes of Health Clinica… | 2022-10-17 → 2030-12-31 | Ouvrir |
| NCT06272968 Predicting Cognition After DBS for Parkinson's Disease 2 |
Predicting Cognition After DBS fo… | Parkinson | À vérifier | ACTIVE_NOT_RECRUITING | En attente / non publié | Charite University, Berlin, Germa… | Germany · Charite - Universitatsmedizin Berlin, Berli… | 2024-10-01 → 2030-12-01 | Ouvrir |
| NCT07802509 HIHA — DOES HIPPOTHERAPY HAVE AN EFFECT ON MOBILITY, GAIT, BALANCE AND … |
HIHA — DOES HIPPOTHERAPY HAVE AN … | Parkinson | Non applicable | RECRUITING | En attente / non publié | Klinik Valens | Switzerland · Rehabilitation Centre Valens, Valens, S… | 2025-01-01 → 2027-01-01 | Ouvrir |
| NCT04932434 PDP1 — Psilocybin Therapy for Depression and Anxiety in Parkinson's Dis… |
Psilocybin therapy | Parkinson | Phase 2 | COMPLETED | En attente / non publié | Joshua Woolley, MD, PhD | United States · University of California, San Francis… | 2021-08-15 → 2024-12-31 | Ouvrir |
| NCT07725562 VG081821AC Tablets for Early to Mid-stage Parkinson's Disease |
VG081821AC | Parkinson | Phase 2/3 | RECRUITING | En attente / non publié | Zhejiang Vimgreen Pharmaceuticals… | China · Xuanwu Hospital of Capital Medical University… | 2026-07-17 → 2027-10-31 | Ouvrir |
| NCT07461220 LIFT-PD — Safety and Tolerability of IRL757 in Participants With Parkin… |
IRL757 | Parkinson | Phase 1/2 | RECRUITING | En attente / non publié | Integrative Research Laboratories… | Bulgaria, Germany, Poland, Spain · Centrum Medyczne N… | 2026-02-18 → 2027-05 | Ouvrir |
| NCT06234995 Cortical Electrophysiology of Response Inhibition in Parkinson's Disease |
Levodopa | Parkinson | Phase 4 | RECRUITING | En attente / non publié | Emory University | United States · Emory Brain Health Center, Atlanta, U… | 2021-08-09 → 2027-09 | Ouvrir |
| NCT06170788 TroFuse-007 — Sacituzumab Tirumotecan (MK-2870) in Combination With Pem… |
Sacituzumab Tirumotecan | Parkinson | Phase 3 | RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Argentina, Australia, Brazil, Canada, … | 2023-12-15 → 2030-05-27 | Ouvrir |
| NCT06618157 Connectomic Guided DBS for Parkinson's Disease |
Cerebellothalamic optimized deep … | Parkinson | Non applicable | ENROLLING_BY_INVITATION | En attente / non publié | Duke University | United States · Duke Health Center at Morreene Road, … | 2026-02-16 → 2027-01-29 | Ouvrir |
| NCT06690931 recoveriX PD — Neurofeedback Rehabilitation With FES and VR for PD |
Brain-Computer Interface with FES… | Parkinson | Non applicable | COMPLETED | En attente / non publié | g.tec medical engineering GmbH | Austria · g.tec medical engineering GmbH, Schiedlberg… | 2024-12-09 → 2026-06-25 | Ouvrir |
| NCT01989013 Effect on Parkinson's Disease After Therapeutic Induction of CranioSacr… |
Effect on Parkinson's Disease Aft… | Parkinson | Non applicable | ENROLLING_BY_INVITATION | En attente / non publié | Zia, Al Raza | United States · Naturalmed therapy, Ann Arbor, United… | 2014-02 → 2027-01 | Ouvrir |
| NCT07216703 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination Wi… |
Pembrolizumab | Parkinson | Phase 3 | RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Argentina, Austria, Belgium, Brazil, C… | 2026-01-19 → 2031-10-29 | Ouvrir |
| NCT04691661 Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib … |
Radotinib HCl 50 mg | Parkinson | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Il-Yang Pharm. Co., Ltd. | France · CHRU de Lille - Hôpital Roger Salengro, Lill… | 2021-09-09 → 2027-04-30 | Ouvrir |
| NCT05824728 AGB101 PDP — Clinical Trial Evaluating the Efficacy and Safety of AGB10… |
AGB101 | Parkinson | Phase 2 | RECRUITING | En attente / non publié | Johns Hopkins University | United States · Johns Hopkins, Baltimore, United Stat… | 2023-09-28 → 2026-12 | Ouvrir |
| NCT03811405 Physiology, Imaging and Modeling of Essential Tremor |
Active biphasic pulse stimulation… | Parkinson | Non applicable | COMPLETED | En attente / non publié | University of Florida | United States · McKnight Brain Institute--Fixel Cente… | 2021-04-01 → 2025-06-01 | Ouvrir |
| NCT05511597 SBT FOG-TRAIN — Split-belt Treadmill Training for Freezing of Gait in P… |
SBT FOG-TRAIN — Split-belt Treadm… | Parkinson | Non applicable | COMPLETED | En attente / non publié | KU Leuven | Belgium · Faculty of Movement and Rehabilitation Scie… | 2022-12-16 → 2026-03-17 | Ouvrir |
| NCT06445972 Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophagea… |
Ramucirumab | Parkinson | Phase 1/2 | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States, Brazil, Chile, China, France, Germany,… | 2024-08-07 → 2030-08-08 | Ouvrir |
| NCT01174498 Pilot Study of the Effect of Transcutaneous Stimulation of the Vagus Ne… |
Cerbomed t-VNS® transcutaneous st… | SEP | Non applicable | COMPLETED | En attente / non publié | cerbomed GmbH | Germany · Klinik und Poliklinik für Psychiatrie und P… | 2009-11 → 2010-09 | Ouvrir |
| NCT06953388 SPARK-VNS — Understanding Non-invasive Vagus Nerve Stimulation Effects … |
transcutaneous auricular vagus ne… | SEP | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | Xijing Hospital | United States · Tolan Park Research Clinic, Wayne Sta… | 2027-04-01 → 2031-03-01 | Ouvrir |
| NCT05301140 Vivistim Registry for Paired VNS Therapy (GRASP) |
Vivistim System | SEP | À vérifier | RECRUITING | En attente / non publié | MicroTransponder Inc. | United States · Advent Health Orlando, Orlando, Unite… | 2023-03-15 → 2028-12-31 | Ouvrir |
| NCT00215215 Effectiveness Study Comparing Treatment With Drug(s) or Adjunctive VNS … |
Vagus Nerve Stimulation Therapy | SEP | Phase 4 | TERMINATED | En attente / non publié | Cyberonics, Inc. | United States · Bronislav Shafran, M.D., P.C., Phoeni… | 2005-02 → 2007-11 | Ouvrir |